Avsana Labs

Avsana Labs is a biotechnology startup and spin-out company from the University of Texas at Dallas (UTD) that seeks to improve viral diagnostic testing using a cutting edge digital nanobubble methodology. Avsana intends to enable a significant societal benefit by helping to mitigate the spread of contagious viral infections, while ultimately helping to reduce the loss of life caused by both current and future pandemics. Avsana’s team includes experienced business executives and entrepreneurs, as well as researchers and technologists with experience in functional nanoparticle development, clinical studies, advance technologies for pathogen detection, and data analysis. Avsana's digital plasmonic nanobubble assay features a rapid turnaround, high throughput, high sensitivity and specificity, and low cost, making it especially suitable for the point-of-care. Our team consists of qualified individuals dedicated to making diagnostic testing more accurate and more accessible through innovative technologies.